Read: All MSF updates on COVID-19
~

Access to Medicines

CHA

Tag: Access to Medicines

Tuberculosis: Policies should ‘help facilitate access to life saving treatment not create barriers.’

Stobdan Kalon is a medical doctor working with Medecins Sans Frontieres/Doctors Without Borders (MSF). His experience spans from managing infectious diseases, interventions in Drug Resistant-Tuberculosis (DR-TB), hepatitis and HIV. As a doctor, I am elated that the World Health Organization...

Read more

Tuberculosis: MSF welcomes WHO revision in TB guidelines and urges greater access and affordability in India to new regimen

New Delhi, India: Doctors Without Borders/Medecins Sans Frontieres (MSF) has welcomed the revision made by the World Health Organisation (WHO) to its tuberculosis (TB) guidelines, allowing for safe use of a treatment regimen including both bedaquiline and delamanid for drug-resistant...

Read more

Access to medicines: Governments must scale up better TB treatment as J&J drops crucial drug price

NEW YORK/GENEVA - The pharmaceutical corporation Johnson & Johnson (J&J) has announced a reduced price of US$1.50 [1] per day for the tuberculosis (TB) drug bedaquiline, which is an important step that should allow more people with drug-resistant forms of TB...

Read more

US trade report could be used to block countries from making affordable COVID-19 medicines

NEW YORK/NEW DELHI —Amidst the ongoing global crisis caused by the COVID-19 pandemic, the United States Trade Representative (USTR) released its annual “Special 301 Report” today that calls out countries for implementing and supporting public health safeguards in their intellectual property laws...

Read more

COVID-19: MSF calls for no patents or profiteering on COVID-19 drugs, tests, and vaccines

GENEVA/NEW YORK — Doctors Without Borders / Médecins Sans Frontières (MSF) has called for no patents or profiteering on drugs, tests, or vaccines used for the COVID-19 pandemic, and for governments to prepare to suspend and override patents and take other measures,...

Read more

World Tuberculosis Day: “It’s time” to end the suffering and accelerate access to all oral regimen

Mumbai (India) - As of February 2020, the MSF private clinic in Govandi, Mumbai has initiated 188 drug-resistant tuberculosis (DR-TB) patients on treatment regimen which includes Bedaquiline and Delamanid. Globally, an estimated 10 million people fell ill with tuberculosis (TB) in 2018...

Read more

Access to medicines: MSF demands review of USTR Special 301 report on trade barriers

In a letter to the United States Trade Representative (USTR) on 6th February 2020, Médecins Sans Frontières (MSF)/Doctors Without Borders submitted comments to the review process of USTR’s 2020 Special 301 Report and raised concerns of the public health impact of...

Read more

MSF: Global vaccines community must urgently support roll out of new more affordable pneumonia vaccine

Global vaccines community must do everything it can to help introduce the new, more affordable pneumonia vaccine in all countries, especially middle-income countries Barcelona – As governments and the global vaccines community gather this week at the first ever Global...

Read more

Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug

As J&J release earnings, MSF protests price of lifesaving TB drug in front of New York Stock Exchange New York, 22 January 2020—Médecins Sans Frontières (MSF) protested in front of the New York Stock Exchange in New York today, demanding...

Read more

Access to medicines: Gavi must ensure more children get new, more affordable pneumonia vaccine

Geneva, 21 January 2020 — As Gavi, the Vaccine Alliance, starts to commemorate its 20th year and launches a new fundraising appeal, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) stressed that more must be done to...

Read more

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...

Read more

Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug

GENEVA - Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons